Sandbox Reserved 390: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 4: Line 4:




<ref name=”Wu CC, Li TK, Farh L, Lin LY, Lin TS, Yu YJ, Yen TJ, Chiang CW, Chan NL. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science. 2011 Jul 22;333(6041):459-62.>PMID: 21778401</ref>
<ref name=”Wu CC, Li TK, Farh L, Lin LY, Lin TS, Yu YJ, Yen TJ, Chiang CW, Chan NL. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science. 2011 Jul 22;333(6041):459-62.</ref>